Skip to main navigation Skip to search Skip to main content

BAP1 and cancer

  • Michele Carbone
  • , Haining Yang
  • , Harvey I. Pass
  • , Thomas Krausz
  • , Joseph R. Testa
  • , Giovanni Gaudino
  • University of Hawai'i at Mānoa
  • New York University
  • University of Chicago

Research output: Contribution to journal › Article › peer-review

581 Scopus citations

Abstract

BAP1 is a deubiquitylase that is found associated with multiprotein complexes that regulate key cellular pathways, including the cell cycle, cellular differentiation, cell death, gluconeogenesis and the DNA damage response (DDR). Recent findings indicate that germline BAP1 mutations cause a novel cancer syndrome that is characterized, at least in the affected families that have been studied so far, by the onset at an early age of benign melanocytic skin tumours with mutated BAP1, and later in life by a high incidence of mesothelioma, uveal melanoma, cutaneous melanoma and possibly additional cancers.

Original languageEnglish
Pages (from-to)153-159
Number of pages7
JournalNature Reviews Cancer
Volume13
Issue number3
DOIs
StatePublished - Mar 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'BAP1 and cancer'. Together they form a unique fingerprint.

Cite this